PCSK9 and diabetes mellitus: Indeed, the link between low PCSK9 levels or its inhibition and LDL-C levels with diabetes suggests a more complex interaction as Mendelian randomization analyses were almost concordant in showing an increased risk of new-onset diabetes in patients treated in the FOURIER and ODYSSEY trials (48).